Amelioration of early cognitive deficits by aged garlic extract in Alzheimer's transgenic mice

Phytotherapy Research

Volumn 21, Issue 7, 2007, Pages 629-640

  Chauhan, Neelima B ^a,b   Sandoval, Jimena ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

A ; Alzheimer's disease; ELISA; Hippocampus; Morris water maze; Tg2576; TgCRND8; Y maze

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; GARLIC EXTRACT;

ADOLESCENT; AGED; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; MEMORY; MOUSE; NONHUMAN; SHORT TERM MEMORY; SPATIAL MEMORY; TASK PERFORMANCE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GARLIC; HIPPOCAMPUS; MALE; MAZE LEARNING; MICE; MICE, TRANSGENIC; PHYTOTHERAPY; PLANT EXTRACTS; SENILE PLAQUES;

ALLIUM SATIVUM; ANIMALIA; MUS; MUS MUSCULUS;

EID: 34447498539     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2122     Document Type: Article

References (67)

1. Agarwal KC. 1996. Therapeutic actions of garlic constituents. Med Res Rev 16: 111-124.
2. Akama KT, Van Eldik LJ. 2000. Beta-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNF alpha receptor-associated factor- and NFkappaB-inducing kinase-dependent signaling mechanism. J Biol Chem 275: 7918-7924.
3. Arendash GW, Gordon MN, Diamond DM et al. 2001. Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory. DNA Cell Biol 20: 737-744.
4. Auld DS, Kornecook TJ, Bastianetto S, Quirion R. 2002. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies. Prog Neurobiol 68: 209-245.
5. Balschun D, Wolfer DP, Gass P et al. 2003. Does cAMP response element-binding protein have a pivotal role in hippocampal synaptic plasticity and hippocampus-dependent memory? J Neurosci 23: 6304-6314.
6. Chauhan NB. 2003. Anti-amyloidogenic effect of Allium sativum in Alzheimer's transgenic model Tg2576. J Herb Pharmacother 3: 95-107.
7. Chauhan NB. 2004. Effect of aged garlic extract on amyloidogenesis and tau phosphorylation in Tg2576 mouse model of AD. Soc Neurosci Abstr, Program No. 674.17.
8. Chauhan NB. 2005. Multiplicity of garlic health effects and Alzheimer's disease. J Nutr Health Aging 9: 421-432.
9. Chauhan NB, Siegel GJ. 2003. Effect of PPF and ALCAR on the induction of NGF- and p75-mRNA and on APP processing in Tg2576 brain. Neurochem Int 43: 225-233.
10. Chauhan NB, Siegel GJ, Feinstein DL. 2005. Propentofylline attenuates tau hyperphosphorylation in Alzheimer's Swedish mutant model Tg2576. Neuropharmacology 48: 93-104.
11. Chishti MA, Yang DS, Janus C et al. 2001. Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276: 21562-21570.
12. Conte V, Uryu K, Fujimoto S et al. 2004. Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury. J Neurochem 90: 758-764.
13. Das P, Murphy MP, Younkin LH, Younkin SG, Golde TE. 2001. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition. Neurobiol Aging 22: 721-727.
14. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. 1991. Subtypes and differential laminar distributions of beta A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol (Berl) 81: 328-335.
15. Dineley KT, Xia X, Bui D, Sweatt JD, Zheng H. 2002. Accelerated plaque accumulation, associative learning deficits, and up-regulation of alpha 7 nicotinic receptor protein in transgenic mice co-expressing mutant human presenilin 1 and amyloid precursor proteins. J Biol Chem 277: 22768-22780.
16. Florian C, Roullet P. 2004. Hippocampal CA3-region is crucial for acquisition and memory consolidation in Morris water maze task in mice. Behav Brain Res 154: 365-374.
17. Geng Z, Rong Y, Lau BH. 1997. S-allyl cysteine inhibits activation of nuclear factor kappa B in human T cells. Free Radic Biol Med 23: 345-350.
18. Gordon MN, King DL, Diamond DM et al. 2001. Correlation between cognitive deficits and Abeta deposits in transgenic APP+PS1 mice. Neurobiol Aging 22: 377-385.
19. Hardy J, Allsop D. 1991. Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12: 383-388.
20. Hardy JA, Higgins GA. 1992. Alzheimer's disease: the amyloid cascade hypothesis. Science 256(5054): 184-185.
21. Holcomb LA, Gordon MN, Jantzen P, Hsiao K, Duff K, Morgan D. 1999. Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits. Behav Genet 29: 177-185.
22. Holcomb L, Gordon MN, McGowan E et al. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97-100.
23. Hsiao K. 1998. Transgenic mice expressing Alzheimer amyloid precursor proteins. Exp Gerontol 33(7-8): 883-889.
24. Hsiao K, Chapman P, Nilsen S et al. 1996. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274(5284): 99-102.
25. Hyde LA, Kazdoba TM, Grilli M et al. 2005. Age-progressing cognitive impairments and neuropathology in transgenic CRND8 mice. Behav Brain Res 160: 344-355. Erratum in: Behav Brain Res 163: 277.
26. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y. 1994. Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron 13: 45-53.
27. Jackson R, McNeil B, Taylor C, Holl G, Ruff D, Gwebu ET. 2002. Effect of aged garlic extract on caspase-3 activity, in vitro. Nutr Neurosci 5: 287-290.
28. Janus C, D'Amelio S, Amitay O et al. 2000a. Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging 21: 541-549.
29. Janus C, Pearson J, McLaurin J et al. 2000b. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408(6815): 979-982.
30. Janus C, Westaway D. 2001. Transgenic mouse models of Alzheimer's disease. Physiol Behav 73: 873-886.
31. Jensen MT, Mottin MD, Cracchiolo JR, Leighty RE, Arendash GW. 2005. Lifelong immunization with human beta-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 130: 667-684.
32. Johnson-Wood K, Lee M, Motter R et al. 1997. Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci USA 94: 1550-1555.
33. Kim KM, Chun SB, Koo MS et al. 2001. Differential regulation of NO availability from macrophages and endothelial cells by the garlic component S-allyl cysteine. Free Radic Biol Med 30: 747-756.
34. Kim W, Hecht MH. 2005. Sequence determinants of enhanced amyloidogenicity of Alzheimer A{beta}42 peptide relative to A{beta}40. J Biol Chem 280: 35069-35076.
35. King DL, Arendash GW, Crawford F, Sterk T, Menendez J, Mullan MJ. 1999. Progressive and gender-dependent cognitive impairment in the APP(SW) transgenic mouse model for Alzheimer's disease. Behav Brain Res 103: 145-162.
36. Kobayashi DT, Chen KS. 2005. Behavioral phenotypes of amyloid-based genetically modified mouse models of Alzheimer's disease. Genes Brain Behav 4: 173-196.
37. Koistinaho M, Ort M, Cimadevilla JM et al. 2001. Specific spatial learning deficits become severe with age in beta-amyloid precursor protein transgenic mice that harbor diffuse beta-amyloid deposits but do not form plaques. Proc Natl Acad Sci USA 98: 14675-14680.
38. Kotilinek LA, Bacskai B, Westerman M et al. 2002. Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J Neurosci 22: 6331-6335.
39. Koudinov AR, Koudinova NV. 2005. Cholesterol homeostasis failure as a unifying cause of synaptic degeneration. J Neurol Sci 229-230: 233-240.
40. Kowalska A. 2004. Genetic aspects of amyloid beta-protein fibrillogenesis in Alzheimer's disease. Folia Neuropathol 42: 235-237.
41. Lorenzo A, Yankner BA. 1994. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91: 12243-12247.
42. Mamiya T, Asanuma T, Kise M et al. 2004. Effects of pre-germinated brown rice on beta-amyloid protein-induced learning and memory deficits in mice. Biol Pharm Bull 27: 1041-1045.
43. Mattson MP, Tomaselli KJ, Rydel RE. 1993. Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF. Brain Res 621: 35-49.
44. Mesulam M, Shaw P, Mash D, Weintraub S. 2004. Cholinergic nucleus basalis tauopathy emerges early in the aging-MCI-AD continuum. Ann Neurol 55: 815-828.
45. Mirra SS, Heyman A, McKeel D et al. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
46. Morgan D, Diamond DM, Gottschall PE et al. 2000. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408(6815): 982-985.
47. Moriguchi T, Matsuura H, Itakura Y, Katsuki H, Saito H, Nishiyama N. 1997a. Allixin, a phytoalexin produced by garlic, and its analogues as novel exogenous substances with neurotrophic activity. Life Sci 61: 1413-1420.
48. Moriguchi T, Matsuura H, Kodera Y et al. 1997b. Neurotrophic activity of organosulfur compounds having a thioallyl group on cultured rat hippocampal neurons. Neurochem Res 22: 1449-1452.
49. Moriguchi T, Saito H, Nishiyama N. 1996. Aged garlic extract prolongs longevity and improves spatial memory deficit in senescence-accelerated mouse. Biol Pharm Bull 19: 305-307.
50. Moriguchi T, Saito H, Nishiyama N. 1997c. Anti-ageing effect of aged garlic extract in the inbred brain atrophy mouse model. Clin Exp Pharmacol Physiol 24: 235-242.
51. Morris RG, Garrud P, Rawlins JN, O'Keefe J. 1982. Place navigation impaired in rats with hippocampal lesions. Nature 297(5868): 681-683.
52. Naslund J, Haroutunian V, Mohs R et al. 2000. Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline. JAMA 283: 1571-1577.
53. Nishiyama N, Moriguchi T, Morihara N, Saito H. 2001. Ameliorative effect of S-allylcysteine, a major thioallyl constituent in aged garlic extract, on learning deficits in senescence-accelerated mice. J Nutr 131(3s): 1093S-1095S.
54. Numagami Y, Ohnishi ST. 2001. S-allylcysteine inhibits free radical production, lipid peroxidation and neuronal damage in rat brain ischemia. J Nutr 131(3s): 1100S-1105S.
55. Ognibene E, Middei S, Daniele S et al. 2005. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease. Behav Brain Res 156: 225-232.
56. Olofsson A, Sauer-Eriksson AE, Ohman A. 2006. The solvent protection of Alzheimer amyloid-beta (1-42) fibrils as determined by solution NMR spectroscopy. J Biol Chem 281: 477-483.
57. Peng Q, Buz'Zard AR, Lau BH. 2002. Neuroprotective effect of garlic compounds in amyloid-beta peptide-induced apoptosis in vitro. Med Sci Monit 8: BR328-BR337.
58. Price DL, Sisodia SS, Borchelt DR. 1998. Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282: 1079-1083.
59. Roher A, Wolfe D, Palutke M, KuKuruga D. 1986. Purification, ultrastructure, and chemical analysis of Alzheimer disease amyloid plaque core protein. Proc Natl Acad Sci USA 83: 2662-2666.
60. Selkoe DJ. 2000. Toward a comprehensive theory for Alzheimer's disease. Hypothesis: Alzheimer's disease is caused by the cerebral accumulation and cytotoxicity of amyloid beta-protein. Ann N Y Acad Sci 924: 17-25.
61. Selkoe DJ. 2004. Cell biology of protein misfolding: the examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol 6: 1054-1061.
62. Stackman RW, Eckenstein F, Frei B, Kulhanek D, Nowlin J, Quinn JF. 2003. Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment. Exp Neurol 184: 510-520.
63. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M. 2002. Amyloid beta-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci USA 99: 13217-13221.
64. Wang J, Dickson DW, Trojanowski JQ, Lee VM. 1999. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging. Exp Neurol 158: 328-337.
65. Westerman MA, Cooper-Blacketer D, Mariash A et al. 2002. The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease. J Neurosci 22: 1858-1867.
66. Yamada N, Hattori A, Hayashi T, Nishikawa T, Fukuda H, Fujino T. 2004. Improvement of scopolamine-induced memory impairment by Z-ajoene in the water maze in mice. Pharmacol Biochem Behav 78: 787-791.
67. Zhang Y, Moriguchi T, Saito H, Nishiyama N. 1998. Functional relationship between age-related immunodeficiency and learning deterioration. Eur J Neurosci 10: 3869-3875.